These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 3374015

  • 1. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE, Becker H, Fuchs HB.
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015
    [Abstract] [Full Text] [Related]

  • 2. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H, Tournoux A, Martenet AC.
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G, Randazzo S, Spina F.
    Ophtalmologie; 1988 Jun; 2(5):431-3. PubMed ID: 3244464
    [No Abstract] [Full Text] [Related]

  • 5. [Effectiveness and tolerance of metipranolol--results of a multi-center long-term study in Switzerland].
    Müller O, Knobel HR.
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):62-3. PubMed ID: 2870216
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
    Yasar T, Ozdemir M, Andi I, Ozdemir G, Simsek S.
    Jpn J Ophthalmol; 2004 Feb; 48(2):172-3. PubMed ID: 15060799
    [No Abstract] [Full Text] [Related]

  • 9. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 10. Carteolol: preliminary study on ocular pressure-reducing action.
    Gorgone G, Spina F, Amantia L.
    Ophthalmologica; 1983 Aug; 187(3):171-3. PubMed ID: 6355953
    [Abstract] [Full Text] [Related]

  • 11. [Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
    Allaire C, Trinquand C, Nordmann JP, Dascotte JC, George JL, Lesure P, Rouland JF, Khaitrine L, Sirbat D.
    J Fr Ophtalmol; 1995 Aug; 18(1):22-6. PubMed ID: 7738291
    [Abstract] [Full Text] [Related]

  • 12. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T, Kitazawa Y, Noma A, Maeda S, Kato A, Ando Y, Ido T, Inazumi K, Hayakawa T, Goto Y, Ichien M.
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].
    Kitazawa Y, Azuma I, Takase M, Komemushi S.
    Nippon Ganka Gakkai Zasshi; 1981 Aug; 85(7):798-804. PubMed ID: 7030018
    [No Abstract] [Full Text] [Related]

  • 15. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 16. [Initial experience with the beta-blocker befunolol in the treatment of open-angle glaucoma in Europe].
    Merté HJ, Stryz JR.
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):55-8. PubMed ID: 6142975
    [Abstract] [Full Text] [Related]

  • 17. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A, Nordmann JP, Baudouin C, Rouland JF, Kadi A, Sartral M.
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [Abstract] [Full Text] [Related]

  • 18. [Epidemiologic and tonometric results of a multicenter study of 5,872 patients with ocular hypertension or open-angle glaucoma treated with betaxolol].
    Bourgeois H.
    Ophtalmologie; 1990 Nov; 4(4):323-5. PubMed ID: 2263381
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [Abstract] [Full Text] [Related]

  • 20. A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants.
    Vercruysse K, Goethals M, Vandeputte O, Missotten L.
    Bull Soc Belge Ophtalmol; 1992 Aug; 245():75-80. PubMed ID: 1344751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.